|
DUSP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.083400E-03 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
4.0023995229177E-10 |
| Stage1-vs-Stage2 |
1.278780E-01 |
| Stage1-vs-Stage3 |
1.714760E-01 |
| Stage1-vs-Stage4 |
7.442200E-01 |
| Stage2-vs-Stage3 |
4.548400E-01 |
| Stage2-vs-Stage4 |
1.349970E-01 |
| Stage3-vs-Stage4 |
1.604000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
3.434300E-04 |
| Normal-vs-Asian |
4.83600000000806E-06 |
| Caucasian-vs-AfricanAmerican |
6.242600E-01 |
| Caucasian-vs-Asian |
4.517800E-01 |
| AfricanAmerican-vs-Asian |
3.736400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40998324127395E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
6.103700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
7.99780019988816E-10 |
| Normal-vs-Age(81-100Yrs) |
2.057800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.801900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.445200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.882400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.811440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.130600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.628600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.685000E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
4.285800E-01 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
1.8440000000286E-06 |
| Tall-VS-Other |
3.076200E-01 |
| Tall-VS-Normal |
2.11539999961374E-07 |
| Follicular-VS-Other |
1.660820E-01 |
| Follicular-VS-Normal |
3.844500E-02 |
| Other-VS-Normal |
1.021440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62470037423645E-12 |
| Normal-vs-N1 |
3.87589960126888E-10 |
| N0-vs-N1 |
1.978990E-03 |
|
|
